Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Evaluation of ETC-1002 in Participants With Hypercholesterolemia and Hypertension

ClinicalTrials.gov ID: NCT02178098

Public ClinicalTrials.gov record NCT02178098. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 5:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Phase 2 study will assess the efficacy and safety of ETC-1002 monotherapy versus placebo in participants with hypercholesterolemia and hypertension.

Study identification

NCT ID
NCT02178098
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Esperion Therapeutics, Inc.
Industry
Enrollment
143 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 16, 2014 (Actual)
Primary completion
May 22, 2015 (Actual)
Completion
May 22, 2015 (Actual)
Last update posted
Apr 4, 2023

2014 – 2015

United States locations

U.S. sites
43
U.S. states
23
U.S. cities
37
Facility City State ZIP Site status
Not listed Birmingham Alabama 35209 —
Not listed Muscle Shoals Alabama 35662 —
Not listed Chandler Arizona 85224 —
Not listed Glendale Arizona 85306 —
Not listed Los Angeles California 90057 —
Not listed DeLand Florida 32720 —
Not listed Fort Lauderdale Florida 33306 —
Not listed Hialeah Florida 33012 —
Not listed Oviedo Florida 32765 —
Not listed Pembroke Pines Florida 33026 —
Not listed Pembroke Pines Florida 33029 —
Not listed Port Orange Florida 32127 —
Not listed Meridian Idaho 83646 —
Not listed Chicago Illinois 60607 —
Not listed Gurnee Illinois 60031 —
Not listed Indianapolis Indiana 46260 —
Not listed Paducah Kentucky 42003 —
Not listed Auburn Maine 04210 —
Not listed Olive Branch Mississippi 38654 —
Not listed Butte Montana 59701 —
Not listed Las Vegas Nevada 89123 —
Not listed Berlin New Jersey 08009 —
Not listed Endwell New York 13760 —
Not listed Wilmington North Carolina 28401 —
Not listed Cincinnati Ohio 45219 —
Not listed Cincinnati Ohio 45245 —
Not listed Cincinnati Ohio 45246 —
Not listed Lyndhurst Ohio 44124 —
Not listed Willoughby Hills Ohio 44094 —
Not listed Tulsa Oklahoma 74136 —
Not listed Eugene Oregon 97404 —
Not listed Downingtown Pennsylvania 19335 —
Site 1 Mt. Pleasant South Carolina 29464 —
Site 2 Mt. Pleasant South Carolina 29464 —
Not listed Simpsonville South Carolina 29681 —
Not listed Corpus Christi Texas 78404 —
Not listed Dallas Texas 75230 —
Not listed Dallas Texas 75234 —
Not listed Houston Texas 77036 —
Not listed Salt Lake City Utah 84107 —
Not listed Salt Lake City Utah 84124 —
Not listed Kenosha Wisconsin 53142 —
Not listed Madison Wisconsin 53719 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02178098, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 4, 2023 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02178098 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →